跳至主要内容
临床试验/NCT04892238
NCT04892238已完成不适用

Helicobacter Pylori Infection Occurrence in Primary Care Settings in Russia

Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology2 个研究点 分布在 1 个国家目标入组 70,000 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70,000
试验地点
2
主要终点
Presence of H.pylori infection

研究概览

简要总结

This study is planned to reveal the occurrence rate of H.pylori infection in ambulatory settings' patients in Russia and to compare the occurrence rates in different years in treatment-naïve and previously treated subjects.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • willingness to participate (based on the signed informed consent form);
  • age older than 12 y.o. (for subjects younger than 18 y.o. written informed consent of a legal representative was obligatory);
  • availability of demographic data and medical history, including previous treatment for H.pylori infection
  • For subjects of "treatment-naïve" group:
  • no previous treatment for H.pylori infection in the anamnesis;
  • at least 6 weeks after previous use of any antimicrobial agents for any reason;
  • at least 2 weeks' time frame free of use of proton pump inhibitors, other anti-secretory agents and bismuth preparations.
  • For "Previously treated" group of subjects:
  • infection caused by H.pylori established earlier and
  • not less than 6 weeks after the end of eradication therapy with at least 2 antibiotics and a proton pump inhibitor for at least 7 days, based on a patient's report

排除标准

  • history of surgery on chest, stomach, gut (excluding appendectomy or laparoscopic cholecystectomy performed more than 6 month before the enrolment);
  • advanced stage of chronic obstructive pulmonary disease,
  • allergies to citruses,
  • pregnant and breastfeeding women.

结局指标

主要结局

Presence of H.pylori infection

时间窗: during the procedure

Delta over the baseline (δ) of 13C/12C based on the results of the initial and second samples ≥4.0‰ are positive

次要结局

未报告次要终点

研究者

发起方
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sergey Morozov

Leading researcher

Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

研究点 (2)

Loading locations...

相似试验

Helicobacter Pylori Infection Occurrence in Russia | 临床试验